Loading...
Inotiv, Inc.
NOTV•NASDAQ
Healthcare
Medical - Diagnostics & Research
$2.22
$-0.14(-5.93%)
Inotiv, Inc. (NOTV) Financial Performance & Income Statement Overview
Review Inotiv, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
-14.27%
↓ 14.27%
Operating Income Growth
-6.07%
↓ 6.07%
Net Income Growth
-3.14%
↓ 3.14%
Operating Cash Flow Growth
-124.41%
↓ 124.41%
Operating Margin
-10.90%
↓ 10.90%
Gross Margin
21.87%
↑ 21.87%
Net Profit Margin
-18.21%
↓ 18.21%
ROE
-51.45%
↓ 51.45%
ROIC
-8.05%
↓ 8.05%
Inotiv, Inc. (NOTV) Income Statement & Financial Overview
Review Inotiv, Inc.'s (NOTV) income statement with detailed quarterly and annual figures.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $119.88M | $130.42M | $105.79M | $119.03M |
| Cost of Revenue | $94.84M | $100.48M | $84.70M | $106.51M |
| Gross Profit | $25.04M | $29.94M | $21.08M | $12.52M |
| Gross Profit Ratio | $0.21 | $0.23 | $0.20 | $0.11 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $24.29M | $25.63M | $21.81M | $25.20M |
| Operating Expenses | $40.55M | $43.11M | $41.83M | $52.94M |
| Total Costs & Expenses | $135.38M | $143.58M | $126.54M | $159.45M |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $13.84M | $12.32M | $12.12M | $11.09M |
| Depreciation & Amortization | $14.18M | $14.59M | $14.12M | $16.36M |
| EBITDA | -$1.79M | $2.87M | -$6.71M | -$26.99M |
| EBITDA Ratio | -$0.01 | $0.02 | -$0.06 | -$0.20 |
| Operating Income | -$15.51M | -$13.17M | -$20.75M | -$40.41M |
| Operating Income Ratio | -$0.13 | -$0.10 | -$0.20 | -$0.34 |
| Other Income/Expenses (Net) | -$14.30M | -$10.88M | -$12.20M | -$11.33M |
| Income Before Tax | -$29.81M | -$24.05M | -$32.95M | -$54.44M |
| Income Before Tax Ratio | -$0.25 | -$0.18 | -$0.31 | -$0.46 |
| Income Tax Expense | -$2.18M | -$5.15M | -$6.86M | -$6.36M |
| Net Income | -$27.63M | -$18.89M | -$26.09M | -$48.08M |
| Net Income Ratio | -$0.23 | -$0.14 | -$0.25 | -$0.40 |
| EPS | -$1.10 | $3.44 | -$1.00 | -$1.86 |
| Diluted EPS | -$1.10 | $3.44 | -$1.00 | -$1.86 |
| Weighted Avg Shares Outstanding | $27.16M | $26.001M | $25.99M | $25.83M |
| Weighted Avg Shares Outstanding (Diluted) | $27.16M | $26.001M | $25.99M | $25.83M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan